Login | Register
Profile | Log out
logo

  • Home
  • News
  • Opinion
  • Other
    • Market Updates
    • Explainers
    • Satire
  • About
  • Contact Us
    • Contact
    • Get Covered
    • Posting Guidelines
  • Subscribe
Submit An Article

Blog

  • Home
  •  
  • Blog



  • Most Read
  • Latest Comments
  • Blog
    • News

    RBA and ASIC up the ante on blockchain project, ASX writes off millions
    Public
  • Blog
    • Satire

    Australia to close borders to Omicron Persei 8
    Public
  • Blog
    • Opinion

    The New Criterion: will the listed sanitiser stocks clean up – or clean out – investors?
    Public
  • Blog
    • Opinion

    Is this the most hated company on the ASX?
    Public
  • Blog
    Opening a new frontier in treating Parkinson’s disease
    • Review
    • November 11, 2022
  • Tremors from the FTX collapse continue to be felt as DigitalX sells off 15% Bitcoin holdings
    • Review
    • January 10, 2023
  • AUDC stablecoin gathers momentum as Novatti confirms integration with XRP Ledger
    • Review
    • June 9, 2022
  • PharmAust completes dosing first cohort for MND treatment, patients respond positively
    • Review
    • January 6, 2023
  • Is this the most hated company on the ASX?
    • Review
    • August 16, 2019

Latest Articles

  • AML3D announces stronger FY26, with positive EBITDA reported in the second half
    AML3D announces stronger FY26, with positive EBITDA reported in the second half
    • News

  • Refurbished tech gives Harris Technology a second life
    Refurbished tech gives Harris Technology a second life
    • News

  • Imagion Biosystems Advances MagSense® Phase 2 Trial
    Imagion Biosystems Advances MagSense® Phase 2 Trial
    • News

  • Acrux-developed Menopause Hormone Therapy to enter Australian market
    Acrux-developed Menopause Hormone Therapy to enter Australian market
    • News

  • Evion Expands Critical Minerals Push with Nevada Fluorspar Option
    Evion Expands Critical Minerals Push with Nevada Fluorspar Option
    • News

  • Beyond Afterpay, who are the next ASX fintech dazzlers?
    • Opinion

    Beyond Afterpay, who are the next ASX fintech dazzlers?

    The $39 billion takeover offer for Afterpay highlights the stupendous potential of our home-grown digital-oriented fintech minnows, bearing in mind the towering buy-now-pay later (BNPL) oak tree was a mere acorn five years ago. Naturally, investor attention has turned to the slew of listed BNPL wannabes who are emulating the Afterpay model with various degrees

    Read More
    Public
  • Austal – from where you’d rather be
    • News

    Austal – from where you’d rather be

    Your journalist would prefer to be on the sandy white beaches of Tahiti right now, sipping a cool mojito and sizzling in the sun.  But, with a long expired passport that won’t be renewed anytime soon, I’m bound to my inner city apartment.  Teasing me, and those locked down across the country is Austal Limited

    Read More
    Public
  • ISA to expand VR gaming for use in military and defence training
    • News

    ISA to expand VR gaming for use in military and defence training

    The ultra realism of first person shooter (FPS) gaming could take on a whole new level with virtual reality entertainment company ISA Group (ASX: IDZ) acquiring VR production studio Red Cartel with the intent of developing VR for use in military and defence operations. Unlike ISA whose primary VR tech is designed for consumer entertainment

    Read More
    Public
  • US Infrastructure Bill sees markets higher
    • News

    US Infrastructure Bill sees markets higher

    Overnight the S&P500 and Dow closed higher as Financials, Energy Industrial and Materials push higher on the back of Bidens 550 billion in infrastructure spending. This will help see the US economy rebound after Covid and opens the door for the Democrats to approve a 3.5 trillion budget to spend further on their social security

    Read More
    Public
  • EMVision’s vision: Point-of-care diagnostic imaging for neurological conditions
    • News

    EMVision’s vision: Point-of-care diagnostic imaging for neurological conditions

    Time is of the essence when a stroke occurs. Each minute that a stroke patient goes without treatment, 1.9 million brain cells die. Early intervention is key and medtech company EMVision Medical Devices (ASX: EMV) wants to help get stroke treatment underway faster. Their point-of-care brain imaging platform allows for rapid diagnosis of neurological conditions

    Read More
    Public
  • Pet-loving tree changers spur a new growth sector for listed vet chain Apiam as demand soars in the pandemic era
    • News

    Pet-loving tree changers spur a new growth sector for listed vet chain Apiam as demand soars in the pandemic era

    The coronavirus may have inflicted global misery but it’s proven a boon for Apiam Animal Health (ASX: AHX), the only remaining listed veterinary play on the ASX after its nearest peers were taken over by private interests. As well as spurring panic pet purchasing, the pandemic spurred thousands of Australians to relocate to rural and

    Read More
    Public
  • «
  • ‹
  • 472
  • 473
  • 474
  • 475
  • 476
  • ›
  • »

Login or register for free to access unlimited reading

Register Now!
  • News

  • Opinion

  • Satire

  • About

  • Contact Us

  • Subscribe

The content published on this website is solely for general information purposes and is not to be construed as financial advice. Should you seek financial advice you should consult with an appropriately qualified person. Opinions expressed on this site are subject to change without notice and The Sentiment who produced this content is under no obligation to keep the information current. The Sentiment, affiliated companies & associates may have a conflict of interest with companies discussed on the website due to commercial arrangements, for example they may be shareholders in the company, be engaged by them to assist in investor communications or receive commission/brokerage for funds raised.

Copyright © 2020 The Sentiment. All rights reserved.
Subscribe

Enter your email address below to subscribe to The Sentiment’s weekly newsletter, highlighting the top news, research, opinion and satire articles shaping ASX investor sentiment.

The Sentiment respects your privacy and will not spam you. View our privacy policy here.